Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Hydrochloride Nasal Spray for Sedation in General Anesthesia Surgery Patients
CTR20210987Phase 3Completed
- Sponsor
- Sichuan Puruite Pharmaceutical Technology
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in anxiety disorder, Not applicable, sponsored by Sichuan Puruite Pharmaceutical Technology. Started May 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorderNot applicable
Beyond the preview
Go deeper on CTR20210987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210987.